Adamas Pharma
(ADMS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2021 | 06-2021 | 03-2021 | 12-2020 | 09-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -44,435 | -24,917 | -12,573 | -57,403 | -39,130 |
| Depreciation Amortization | 336 | 186 | 70 | 716 | 508 |
| Accounts receivable | -2,004 | -2,061 | -4,379 | -2,272 | -1,878 |
| Accounts payable and accrued liabilities | 1,978 | 232 | 130 | -4,979 | -2,382 |
| Other Working Capital | -8,446 | -9,002 | -10,133 | -15,200 | -9,206 |
| Other Operating Activity | 16,085 | 5,321 | 5,822 | 28,430 | 11,707 |
| Operating Cash Flow | $-36,486 | $-30,241 | $-21,063 | $-50,708 | $-40,381 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -20,701 | -17,701 | 9,117 | 37,874 | 7,964 |
| PPE Investments | -38 | -30 | N/A | N/A | N/A |
| Net Acquisitions | -1,327 | -1,327 | -1,327 | N/A | N/A |
| Sale Of Investment | 0 | 0 | N/A | 17,066 | 17,066 |
| Investing Cash Flow | $-22,066 | $-19,058 | $7,790 | $54,940 | $25,030 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 2,650 | 2,650 |
| Debt Repayment | -1,660 | -705 | -426 | N/A | 0 |
| Common Stock Issued | 66,778 | 66,744 | 66,870 | 1,217 | 157 |
| Other Financing Activity | 397 | 397 | 0 | -2,213 | -2,427 |
| Financing Cash Flow | $65,515 | $66,436 | $66,444 | $1,654 | $380 |
| Beginning Cash Position | 71,660 | 71,660 | 71,660 | 65,774 | 65,774 |
| End Cash Position | 78,623 | 88,797 | 124,831 | 71,660 | 50,803 |
| Net Cash Flow | $6,963 | $17,137 | $53,171 | $5,886 | $-14,971 |
| Free Cash Flow | |||||
| Operating Cash Flow | -36,486 | -30,241 | -21,063 | -50,708 | -40,381 |
| Capital Expenditure | -38 | -30 | N/A | N/A | 0 |
| Free Cash Flow | -36,524 | -30,271 | -21,063 | -50,708 | -40,381 |